Aligning with those findings, VEGFR2 inhibition in our study was found to enhance the translocation of PGC1α into nucleus and promote mitochondrial biogenesis in glioblastoma cells (Figs. 2 and 5). The gene discussed is KDR; the disease is glioblastoma.